Launching a new pharmaceutical treatment is a high-stakes process that requires a deep understanding of the market, regulatory considerations, and the perspectives of key stakeholders—physicians, patients, and payers. While each audience provides valuable insights, too often, pharmaceutical companies gather this information in silos, using separate research vendors for each group, particularly payers.
This fragmented approach misses critical connections between stakeholders, which can lead to misaligned strategies or overlooked market nuances. By working with a single, integrated market research partner, companies can synthesize insights more effectively, ensuring their launch strategy is both comprehensive and cohesive. Here’s why an integrated approach enhances decision-making and market success.
1. Connecting the Dots Between Stakeholders
A single research partner can synthesize findings across all three audiences, identifying these intersections in real time, rather than after separate, disjointed studies.
- How do physicians’ prescribing priorities align with payer reimbursement requirements?
- Do the reasons behind patient adherence match what doctors and payers expect? Will the patients comply with proposed strategies by the healthcare system?
- Are there gaps between what doctors believe about affordability and what patients actually experience?
2. Ensuring Consistency in Research Approach and Analysis
Using multiple vendors often results in variability in methodology, terminology, and data interpretation, making it difficult to align insights. With one research partner, companies gain:
- A consistent approach to research design, question framing, and analysis.
- Stronger cross-stakeholder comparisons to highlight market gaps and opportunities.
- More reliable synthesis of qualitative findings.
3. Accelerating Decision-Making and Strategy Refinement
With siloed research, teams must spend extra time manually integrating insights and reconciling discrepancies. A single vendor streamlines this process by:
- Delivering cross-stakeholder insights faster, reducing time to strategic action.
- Providing cohesive storytelling that connects payer expectations, physician behavior, and patient realities.
- Facilitating agile decision-making, enabling real-time strategy adjustments as new insights emerge.
A Smarter Way to Build Market-Ready Strategies
A fragmented research approach can lead to strategic misalignment, miscommunication, and missed market opportunities. Partnering with a single, integrated research vendor ensures cohesive insights, streamlined decision-making, and stronger market execution. At Egeria Insights, we have extensive experience with all stakeholders and understand the need to weave a thread through each of the discussions to produce a comprehensive analysis and recommendation.
We help you to understand how doctors, patients, and payers interact within the treatment landscape, allowing you to launch more effectively, ensuring faster uptake, better positioning, and long-term success—for the company and, most importantly, for the patients who need these treatments most.
